Hepatitis C virus (HCV) infection is a systemic disease associated with multiple significant
extrahepatic manifestations. Emerging studies indicate association between the HCV …

The eradication of the hepatitis C virus (HCV) has revolutionized the hepatology paradigm,
halting the progression of advanced liver disease in patients with chronic infection and …

The treatment of chronic hepatitis C (CHC) has been revolutionized in an era of all-oral
direct-acting antivirals (DAAs) since 2014. Satisfactory treatment efficacy and tolerability can …

Hepatitis C virus (HCV) eradication deteriorates lipid profiles. Although HCV eradication
may reduce the risk of vascular events as a whole, whether deteriorated lipid profiles …

Screening recommendations and treatment guidelines for hepatitis C virus (HCV) infection
have been updated. People at the greatest risk of HCV infection are those between 18 and …

Background The role of hepatitis C virus (HCV) infection statuses in the development of type
2 diabetes mellitus (T2DM) has not been completely understood. Aim To evaluate the …

Difficult-to-treat populations with chronic hepatitis C (CHC), in the era of interferon treatment,
included patients with liver cirrhosis, kidney impairment, treatment-experienced individuals …

Background and Aims. Chronic hepatitis C is a systemic disease and type 2 diabetes
mellitus (T2DM) belongs to more common extrahepatic. The aim of this study was to (i) …

The advent of highly effective and well‐tolerated direct antiviral antivirals (DAAs) has
dramatically changed the landscape of chronic hepatitis C. The effect of DAAs in older adults …

Abstract Background Chronic hepatitis C (CHC) virus infection is a global health concern
that is associated with significant liver-related morbidity and mortality. Owing to the …